Safety of the cell-penetrating peptide penetratin as an oral absorption enhancer

Biological and Pharmaceutical Bulletin

Volumn 38, Issue 1, 2015, Pages 144-146

  Nielsen, Ebbe Juel Bech ^a,b   Kamei, Noriyasu ^a   Takeda Morishita, Mariko ^a  

^a KOBE GAKUIN UNIVERSITY   (Japan)

^b NOVO NORDISK A S   (Denmark)

Author keywords

Absorption enhancer; Cell penetrating peptide; Lipopolysaccharide; Oral delivery; Penetratin; Toxicity

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILE SALT; LIPOPOLYSACCHARIDE; PENETRATIN; CARRIER PROTEIN; CELL PENETRATING PEPTIDE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; DRUG SAFETY; INTESTINE EPITHELIUM; LIVER INJURY; MALE; MOUSE; NONHUMAN; WEIGHT GAIN; ANIMAL; BLOOD; INTESTINE ABSORPTION; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; CARRIER PROTEINS; CELL-PENETRATING PEPTIDES; INTESTINAL ABSORPTION; LIPOPOLYSACCHARIDES; MALE; MICE;

EID: 84920523007     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.b14-00517     Document Type: Article

References (15)

1. Morishita M, Khafagy ES, Shofner J P, Peppas NA. Oral Delivery Systems. (Morishita M, Park K, ed.) 1st Ed., Informa Healthcare, 2009.
2. Morishita M, Peppas NA. Advances in oral drug delivery: improved bioavailability of poorly absorbed drugs by tissue and cellular optimization. Preface. Adv. Drug Deliv. Rev., 64, 479 (2012).
3. Rekha MR, Sharma CP. Oral delivery of therapeutic protein/peptide for diabetesfuture perspectives. Int. J. Pharm., 440, 48-62 (2013).
4. Khafagy el-S, Morishita M, Kamei N, Eda Y, Ikeno Y, Takayama K. Efficiency of cell-penetrating peptides on the nasal and intestinal absorption of therapeutic peptides and proteins. Int. J. Pharm., 381, 49-55 (2009).
5. Nielsen E J B, Yoshida Y, Kamei N, Iwamae R, Khafagy el-S, Olsen J, Rahbek YL, Pedersen BL, Takayama K, Takeda-Morishita M. In vivo proof of concept of oral insulin delivery based on a coadministration strategy with the cell-penetrating peptide penetratin. J. Control. Release, 189, 19-24 (2014).
6. Khafagy el-S, Kamei N, Nielsen E J B, Nishio R, Takeda-Morishita M. One-month subchronic toxicity study of cell-penetrating peptides for insulin nasal delivery in rats. Eur. J. Pharm. Biopharm., 85(3 Pt A), 736-743 (2013).
7. Nolan JP. Intestinal endotoxins as mediators of hepatic injuryan idea whose time has come again. Hepatology, 10, 887-891 (1989).
8. Leist M, Gantner F, Bohlinger I, Tiegs G, Germann PG, Wendel A. Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models. Am. J. Pathol., 146, 1220-1234 (1995).
9. Sonaje K, Lin KJ, Tseng MT, Wey SP, Su FY, Chuang EY, Hsu CW, Chen CT, Sung H W. Effects of chitosan-nanoparticle-mediated tight junction opening on the oral absorption of endotoxins. Biomaterials, 32, 8712-8721 (2011).
10. Akase T, Shimada T, Harasawa Y, Akase T, Ikeya Y, Nagai E, Iizuka S, Nakagami G, Iizaka S, Sanada H, Aburada M. Preventive effects of salacia reticulata on obesity and metabolic disorders in tsod mice. Evid. Based Complement. Alternat. Med., 2011, 484590 (2011).
11. Fujimoto M, Tsuneyama K, Chen SY, Nishida T, Chen JL, Chen YC, Fujimoto T, Imura J, Shimada Y. Study of the effects of monacolin k and other constituents of red yeast rice on obesity, insulinresistance, hyperlipidemia, and nonalcoholic steatohepatitis using a mouse model of metabolic syndrome. Evid. Based Complement. Alternat. Med., 2012, 892697 (2012).
12. Nakajima T, Tanaka N, Kanbe H, Hara A, Kamijo Y, Zhang X, Gonzalez FJ, Aoyama T. Bezafibrate at clinically relevant doses decreases serum/liver triglycerides via down-regulation of sterol regulatory element-binding protein-1c in mice: a novel peroxisome proliferator-activated receptor alpha-independent mechanism. Mol. Pharmacol., 75, 782-792 (2009).
13. Maher S, Leonard TW, Jacobsen J, Brayden DJ. Safety and efficacy of sodium caprate in promoting oral drug absorption: from in vitro to the clinic. Adv. Drug Deliv. Rev., 61, 1427-1449 (2009).
14. Kamei N, Onuki Y, Takayama K, Takeda-Morishita M. Mechanistic study of the uptake/permeation of cell-penetrating peptides across a caco-2 monolayer and their stimulatory effect on epithelial insulin transport. J. Pharm. Sci., 102, 3998-4008 (2013).
15. Renukuntla J, Vadlapudi AD, Patel A, Boddu S H S, Mitra AK. Approaches for enhancing oral bioavailability of peptides and proteins. Int. J. Pharm., 447, 75-93 (2013).